Challenges in clinical trial design for recurrent glioblastoma

Author： McNeill Katharine A   Fine Howard A  

Publisher： Future Science

ISSN： 2041-6792

Source： Clinical Investigation, Vol.3, Iss.9, 2013-09, pp. : 835-848

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Signal Transduction Therapy: Challenges to Clinical Trial Design

By  

Current Signal Transduction Therapy, Vol. 2, Iss. 1, 2007-01 ,pp. : 21-30

Bentham Science Publishers

Access to resources Recommend Favorite

Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial

By  

Oncology, Vol. 83, Iss. 1, 2012-06 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

Tools to improve clinical trial design in urothelial cancer

By  

CANCER, Vol. 119, Iss. 16, 2013-08 ,pp. : 2950-2952

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nocebo vs. Placebo: The Challenges of Trial Design in Analgesia Research

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 2, 2015-02 ,pp. : 143-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second-Line Chemotherapy in Recurrent Glioblastoma - Still Controversial

By  

Oncology Research and Treatment, Vol. 38, Iss. 7-8, 2015-07 ,pp. : 345-346

Karger

Access to resources Recommend Favorite